Maxim Group analyst Anthony Vendetti reiterated a Sell rating on National Beverage (FIZZ) today and set a price target of $45. The company’s shares closed yesterday at $84.30, close to its 52-week low of $81.11.
“Market close, FIZZ reported F2Q19 (Oct) revenue and EBITDA below both our estimates and consensus. We believe LaCroix sales growth decelerated sharply in a lawsuit claimed that the product contains certain questionable ingredients. The company announced a special dividend of $2.90 per share, payable on or about the ex-dividend date was November 29, 2018. Note that the CEO owns 73% of the stock.”
According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 6.4% and a 48.9% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Ellex Medical Lasers Limited, Restoration Robotics Inc, and Xtant Medical Holdings.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for National Beverage with a $98.25 average price target, implying a 16.5% upside from current levels. In a report issued on November 29, Guggenheim also maintained a Sell rating on the stock with a $83 price target.
National Beverage’s market cap is currently $3.93B and has a P/E ratio of 24.65. The company has a Price to Book ratio of 10.39.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
National Beverage Corp. engages in the development, manufacture, market, and sale of flavored beverage products. Its brands include Shasta, Faygo, Everfresh, LaCroix, Rip It, Asante, Mt. Shasta, ClearFruit, Mr. Pure, Ritz, Crystal Bay, Cascadia Sparkling Clear, Cascadia Only 2 Calories, Ohana, Big Shot, and St. Nick’s.